The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure

被引：34

作者：

Nazha, Aziz ^{[1
,2
]}

Komrokji, Rami S. ^{[3
]}

Garcia-Manero, Guillermo ^{[4
]}

Barnard, John ^{[5
]}

Roboz, Gail J. ^{[6
]}

Steensma, David P. ^{[7
]}

DeZern, Amy E. ^{[8
]}

Zell, Katrina ^{[5
]}

Zimmerman, Cassie ^{[1
,2
]}

Al Ali, Najla ^{[3
]}

Jabbour, Elias ^{[4
]}

Greenberg, Molly D. ^{[6
]}

Kantarjian, Hagop M. ^{[4
]}

Maciejewski, Jaroslaw P. ^{[1
,2
]}

List, Alan F. ^{[3
]}

Sekeres, Mikkael A. ^{[1
,2
]}

机构：

[1] Cleveland Clin, Leukemia Program, Cleveland, OH 44106 USA

[2] Cleveland Clin, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[5] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA

[6] New York Presbyterian Hosp, Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY USA

[7] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[8] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

来源：

关键词：

MDS; hypomethylating agent; prognostic models; SCORING SYSTEM; CLASSIFICATION; AZACITIDINE; PROPOSAL;

D O I：

10.3324/haematol.2015.140962

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E224 / E227

页数：4

共 43 条